Even though the scientific relevance with the aforementioned cardiovascular danger factor alterations by tirzepatide will likely be assessed within the prepared cardiovascular consequence research SURPASS-CVOT ( "style":"medical-trial","attrs": "text":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Investigat